Evidence map›Paper›PMID 40144349›Full record

ArticleCancer informatics2025

Twenty Year History of Cancer Informatics (CiX) - A Long and Established Legacy of Quality Research and Scientific Advances in the Field of Oncology.

Jimmy T Efird

Abstract readEditorial
In one paragraph

Article in Cancer informatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jimmy T EfirdDepartment of Radiation Oncology, Case-Western Reserve University School of Medicine, Cleveland, OH, USA.ORCID https://orcid.org/0000-0002-4890-5111

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over a 20 year period, the journal Cancer Informatics has played an important role defining and forging a bridge between bioinformations and translational cancer research. The main focus of the journal has been to advance the prevention, diagnosis, and treatment of cancer. This involves the specialized intersection of genomics, molecular biology, data science, computer programing, statistics, communication theory, and the clinical sciences to answer important questions in the field of cancer research.

Indexed as

bioinformaticscancer informaticscomputational biologycomputer sciencegenomicsstatistics

Identifiers

PMID40144349
PMCPMC11938436

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.